Compagnie DE Developpement Aguettant
French pharmaceutical company focused on manufacture and supply of sterile, ready-to-administer injectable medicines and related diagnostic activities. Operates multiple industrial sites and a network of commercial affiliates, provides sterile filling and packaging (including pre-filled syringes, ampoules, vials and infusion bags), conducts R&D in proteomics and diagnostics, and maintains environmental management and regulatory systems including ISO 14001 and an EcoVadis rating.
Industries
N/A
Nr. of Employees
small (1-50)
Compagnie DE Developpement Aguettant
Products
Pre-filled polypropylene syringes (5 ml and 10 ml)
Ready-to-administer pre-filled syringe dosage forms intended to reduce medication errors and preparation time in hospital environments.
Sterile glass ampoules and glass bottles
Production and packaging of sterile glass ampoules and bottles for injectable medicines.
Polypropylene single-dose ampoules (BFS, 5 ml and 10 ml)
Single‑dose polypropylene ampoules manufactured by blow–fill–seal for sterile liquid products.
Sterile infusion bags (50 ml to 1 L)
Manufacture of sterile infusion solutions in single-use bags for clinical use.
Cartridges and auto-injector formats
Cartridge-based delivery formats and auto‑injector pens as alternative drug delivery systems.
Pre-filled polypropylene syringes (5 ml and 10 ml)
Ready-to-administer pre-filled syringe dosage forms intended to reduce medication errors and preparation time in hospital environments.
Sterile glass ampoules and glass bottles
Production and packaging of sterile glass ampoules and bottles for injectable medicines.
Polypropylene single-dose ampoules (BFS, 5 ml and 10 ml)
Single‑dose polypropylene ampoules manufactured by blow–fill–seal for sterile liquid products.
Sterile infusion bags (50 ml to 1 L)
Manufacture of sterile infusion solutions in single-use bags for clinical use.
Cartridges and auto-injector formats
Cartridge-based delivery formats and auto‑injector pens as alternative drug delivery systems.
Services
Establishing license or distribution partnerships for specialty pharmaceuticals and ready-to-administer injectable products across Europe and selected international markets.
Management of post‑marketing safety reports, product complaints and regulatory notifications in compliance with applicable legal obligations and data protection requirements.
Establishing license or distribution partnerships for specialty pharmaceuticals and ready-to-administer injectable products across Europe and selected international markets.
Management of post‑marketing safety reports, product complaints and regulatory notifications in compliance with applicable legal obligations and data protection requirements.
Expertise Areas
- Hospital injectable medicines
- Ready-to-administer injectable formulation development
- Anesthesia and critical care therapeutics
- Analgesia (pain management)
Key Technologies
- Blow-fill-seal (BFS) filling
- Extrusion molding for polymer containers
- Prefilled syringe filling and sterile packaging
- Aseptic filling and sterile processing
News & Updates
Official visit highlighting national health and industrial sovereignty; topics included relocation of critical drug production and active ingredient production in France.
Completion of a €40 million expansion project increasing production capacity across three French sites, including a new 10 ml pre-filled syringe line and a doubled ampoule line.
Acquisition and integration of a manufacturing site dedicated to infusion bags, increasing production capacity and industrial footprint.
Awarded a silver medal by EcoVadis, ranking in the top assessed companies for CSR performance across environment, labor & human rights, ethics and sustainable procurement.
Published CSR/RSE report summarizing environmental initiatives, energy and water savings, waste management and sustainability performance.
Certification for environmental management systems by Bureau Veritas.
Official visit highlighting national health and industrial sovereignty; topics included relocation of critical drug production and active ingredient production in France.
Completion of a €40 million expansion project increasing production capacity across three French sites, including a new 10 ml pre-filled syringe line and a doubled ampoule line.
Acquisition and integration of a manufacturing site dedicated to infusion bags, increasing production capacity and industrial footprint.
Awarded a silver medal by EcoVadis, ranking in the top assessed companies for CSR performance across environment, labor & human rights, ethics and sustainable procurement.
Published CSR/RSE report summarizing environmental initiatives, energy and water savings, waste management and sustainability performance.
Certification for environmental management systems by Bureau Veritas.